Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127966251 | 12796625 | 1 | I | 20150819 | 20160926 | 20160929 | 20160929 | EXP | GB-MHRA-EYC 00145575 | GB-PFIZER INC-2016450818 | PFIZER | 6.00 | YR | F | Y | 15.00000 | KG | 20160929 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127966251 | 12796625 | 1 | PS | MEROPENEM. | MEROPENEM | 1 | Oral | 150 MG, 3X/DAY | 1800 | MG | D | 90940 | 150 | MG | TID | ||||
| 127966251 | 12796625 | 2 | C | CEFOTAXIME | CEFOTAXIME SODIUM | 1 | 0 | ||||||||||||
| 127966251 | 12796625 | 3 | C | GENTAMICIN. | GENTAMICIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127966251 | 12796625 | 1 | Urinary tract infection bacterial |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127966251 | 12796625 | HO |
| 127966251 | 12796625 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127966251 | 12796625 | Multiple organ dysfunction syndrome | |
| 127966251 | 12796625 | Pancreatitis acute |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127966251 | 12796625 | 1 | 20150815 | 20150829 | 0 |